Revance Therapeutics, Inc. (RVNC) News

Revance Therapeutics, Inc. (RVNC): $3.65

0.01 (+0.27%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add RVNC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#98 of 337

in industry

Filter RVNC News Items

RVNC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!